| Title |
The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, August 2014
|
| DOI | 10.2147/ndt.s68951 |
| Pubmed ID | |
| Authors |
Robert L. Findling, Lawrence Ginsberg |
| Abstract |
To assess the safety and effectiveness of open-label treatment with extended-release carbamazepine (ERC) in pediatric subjects suffering from bipolar I disorder. |
Mendeley readers
The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 49 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 8 | 16% |
| Student > Doctoral Student | 5 | 10% |
| Researcher | 5 | 10% |
| Student > Postgraduate | 5 | 10% |
| Other | 3 | 6% |
| Other | 8 | 16% |
| Unknown | 15 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 31% |
| Psychology | 12 | 24% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 6% |
| Social Sciences | 1 | 2% |
| Neuroscience | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 16 | 33% |